A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Rodger David MacArthur, Richard M. Novak, Grace Peng, Ying Xiang, Katherine Huppler Hullsiek, Michael J. Kozal, Mary van den Berg-Wolf, Christopher Henely, Barry Schmetter, Marjorie Dehlinger

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences